1. Home
  2. TY vs PGEN Comparison

TY vs PGEN Comparison

Compare TY & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tri Continental Corporation

TY

Tri Continental Corporation

HOLD

Current Price

$33.17

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.93

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TY
PGEN
Founded
1929
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TY
PGEN
Price
$33.17
$4.93
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.67
AVG Volume (30 Days)
43.0K
3.4M
Earning Date
01-01-0001
03-18-2026
Dividend Yield
3.36%
N/A
EPS Growth
N/A
N/A
EPS
4.78
N/A
Revenue
N/A
$6,309,000.00
Revenue This Year
N/A
$342.78
Revenue Next Year
N/A
$478.46
P/E Ratio
$6.38
N/A
Revenue Growth
N/A
59.20
52 Week Low
$25.16
$1.11
52 Week High
$30.73
$5.23

Technical Indicators

Market Signals
Indicator
TY
PGEN
Relative Strength Index (RSI) 49.04 58.55
Support Level $32.82 $4.41
Resistance Level $33.69 $5.00
Average True Range (ATR) 0.35 0.38
MACD 0.01 0.02
Stochastic Oscillator 40.23 90.00

Price Performance

Historical Comparison
TY
PGEN

About TY Tri Continental Corporation

Tri-Continental Corp is a United States-based closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: